A detailed history of Omers Administration Corp transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Omers Administration Corp holds 50,800 shares of ROIV stock, worth $542,544. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,800
Previous 101,600 50.0%
Holding current value
$542,544
Previous $1.17 Million 48.81%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$11.16 - $12.71 $566,928 - $645,668
-50,800 Reduced 50.0%
50,800 $600,000
Q3 2024

Nov 13, 2024

SELL
$10.17 - $12.5 $635,625 - $781,250
-62,500 Reduced 38.09%
101,600 $1.17 Million
Q2 2024

Aug 13, 2024

BUY
$10.36 - $11.74 $1.7 Million - $1.93 Million
164,100 New
164,100 $1.73 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.52B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.